Protective Efficacy of Plasmodium vivax Radiation-Attenuated Sporozoites in Colombian Volunteers: A Randomized Controlled Trial.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 27760143)

Published in PLoS Negl Trop Dis on October 19, 2016

Authors

Myriam Arévalo-Herrera1,2, Juan M Vásquez-Jiménez1, Mary Lopez-Perez1, Andrés F Vallejo1, Andrés B Amado-Garavito1, Nora Céspedes1, Angélica Castellanos1, Karen Molina1, Johanna Trejos3, José Oñate4, Judith E Epstein5, Thomas L Richie6, Sócrates Herrera1,7

Author Affiliations

1: Malaria Vaccine and Drug Development Center (MVDC), Cali, Colombia.
2: Faculty of Health, Universidad del Valle, Cali, Colombia.
3: Asoclinic Inmunología LTDA, Cali, Colombia.
4: Centro Médico Imbanaco, Cali, Colombia.
5: Naval Medical Research Center, Malaria Department, Silver Spring, Maryland, United States of America.
6: Sanaria Inc, Rockville, Maryland, United States of America.
7: Caucaseco Scientific Research Center, Cali, Colombia.

Associated clinical trials:

Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites (SPZ-Irrad) | NCT01082341

Articles citing this

Plasmodium vivax Controlled Human Malaria Infection - Progress and Prospects. Trends Parasitol (2016) 0.76

Articles cited by this

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis (2002) 5.43

Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci (1973) 4.18

Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg (1975) 3.32

The complexity of protective immunity against liver-stage malaria. J Immunol (2000) 2.92

Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci U S A (2010) 2.79

Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans R Soc Trop Med Hyg (1974) 2.22

Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am J Med Sci (1973) 1.84

How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell (2015) 1.34

Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. Parasite Immunol (2002) 1.32

Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75. Bull World Health Organ (1990) 1.26

Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit. Am J Trop Med Hyg (2005) 1.23

Protection against malaria induced by irradiated sporozoites. Lancet (1990) 1.10

Consistent safety and infectivity in sporozoite challenge model of Plasmodium vivax in malaria-naive human volunteers. Am J Trop Med Hyg (2011) 1.09

Molecular evidence of Plasmodium vivax mono and mixed malaria parasite infections in Duffy-negative native Cameroonians. PLoS One (2014) 1.06

Successful sporozoite challenge model in human volunteers with Plasmodium vivax strain derived from human donors. Am J Trop Med Hyg (2009) 1.04

Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis. BMC Med (2014) 1.02

Plasmodium vivax sporozoite challenge in malaria-naïve and semi-immune Colombian volunteers. PLoS One (2014) 1.02

Regular production of infective sporozoites of Plasmodium falciparum and P. vivax in laboratory-bred Anopheles albimanus. Ann Trop Med Parasitol (1997) 0.99

Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines. Vaccine (2015) 0.95

Plasmodium vivax sporozoite production in Anopheles albimanus mosquitoes for vaccine clinical trials. Am J Trop Med Hyg (2011) 0.91

Antigenicity and immunogenicity of a novel chimeric peptide antigen based on the P. vivax circumsporozoite protein. Vaccine (2013) 0.89

Development of sporogonic cycle of Plasmodium vivax in experimentally infected Anopheles albimanus mosquitoes. Mem Inst Oswaldo Cruz (1994) 0.85

Protective immunity induced by daily bites from irradiated mosquitoes infected with Plasmodium yoelii. Parasite Immunol (2008) 0.83

Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development. PLoS One (2015) 0.82

Malaria vaccines: identifying Plasmodium falciparum liver-stage targets. Front Microbiol (2015) 0.81

Immune responses and protection of Aotus monkeys immunized with irradiated Plasmodium vivax sporozoites. Am J Trop Med Hyg (2011) 0.80

Validation of a method for the simultaneous quantification of chloroquine, desethylchloroquine and primaquine in plasma by HPLC-DAD. J Pharm Biomed Anal (2014) 0.80

Optimization of a Membrane Feeding Assay for Plasmodium vivax Infection in Anopheles albimanus. PLoS Negl Trop Dis (2016) 0.77